Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation

BIGSdb: Scalable analysis of bacterial genome variation at the population level

(2011) Keith A Jolley et al.   BMC BIOINFORMATICS

Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine

(2010) J. Lucidarme et al.   Clinical and Vaccine Immunology

The Human Oral Microbiome

(2010) F. E. Dewhirst et al.   JOURNAL OF BACTERIOLOGY

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs

(2009) Caroline L Trotter et al.   Expert Review of Vaccines

Meningococcal carriage and disease—Population biology and evolution

(2009) Dominique A. Caugant et al.   VACCINE

Quadrivalent meningococcal conjugate vaccines

(2009) David Pace et al.   VACCINE

Meningococcal C conjugate vaccine: The experience in England and Wales

(2009) Helen Campbell et al.   VACCINE

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis

(2009) David S. Stephens   VACCINE

Global epidemiology of meningococcal disease

(2009) Lee H. Harrison et al.   VACCINE

Economics of an Adolescent Meningococcal Conjugate Vaccination Catch-up Campaign in the United States

(2008) Ismael R. Ortega Sanchez et al.   CLINICAL INFECTIOUS DISEASES

B:2a:P1.5 Meningococcal Strains Likely Arisen from Capsular Switching Event Still Spreading in Spain

(2008) J. Castilla et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

(2008) Martin C. J. Maiden et al.   JOURNAL OF INFECTIOUS DISEASES

Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines

(2008) J. E. Russell et al.   MICROBIOLOGY-SGM

Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis

(2008) C. O. Buckee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

(2008) Caroline L. Trotter et al.   VACCINE

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa

(2008) Brown J. Okoko et al.   VACCINE